CBER Expertise
Office of Cellular, Tissue and Gene Therapies
Division of Cellular and Gene Therapies
Raj K. Puri, MD, PhD, Director
Kimberly A. Benton, PhD, Deputy Director
Gene Transfer and Immunogenicity Branch
- Eda T. Bloom, PhD, Chief - Evaluating and predicting the effects on safety and efficacy of immune responses to cell therapy and xenotransplantation products
- Suzanne L. Epstein, PhD - Reduction of virus infection by immunity induced by vaccines or vectors
- Carolyn A. Wilson, PhD - Viral safety studies in xenotransplantation and gene therapy products
- Andrew Byrnes, PhD - Safety and efficiency of gene therapy
Tumor Vaccines and Biotechnology Branch
- Raj Puri, MD, PhD, Acting Chief - Development of safe and effective tumor vaccines and gene therapy products
- Michail A. Alterman, PhD - Analytical proteomics as a tool for the characterization of biologic products and discovery and validation of biomarkers.
Cellular and Tissue Therapy Branch
- Steven R. Bauer, PhD, Acting Chief - Assuring safety and efficacy of stem-cell based products
- Brenton McCright, PhD - Developing measures of safety and efficacy for tissue-engineered products
- Malcolm Moos, MD, PhD - Predicting the safety and efficacy of cell and tissue products used for repair of damaged tissue and structures through cell growth and maturation pathways
- Deborah Hursh, PhD - Developing predictive indicators of cell maturation as indicators of cell therapy product efficacy and safety
- Gerald Marti, MD - Flow cytometry: a way to characterize cell populations